Most clinicians who responded to a survey said their hospitals and institutions did not include palliative care as part of their protocol for treating patients who are implanted with cardiovascular device-based therapies, including transcatheter aortic valve replacement (TAVR) and ventricular assist devices (VADs).

A recent survey found that only half of women from 25 to 60 years old knew that heart disease was the leading threat to women’s lives, NPR reports.

Silent MIs accounted for more than 45 percent of MIs in a group of nearly 10,000 participants from a community-based cohort study who did not have cardiovascular disease at baseline.

A law firm in California sued Theranos, Inc. on May 26 for misrepresenting the accuracy and quality of its blood tests, Reuters reports. The Wall Street Journal reported earlier this month that Theranos admitted to federal government officials that the company voided reports in 2014 and 2015 from its Edison blood testing devices.

Medtronic and Qualcomm, Inc. announced a partnership to develop continuous glucose monitoring systems for patients with type 2 diabetes.

The American Heart Association (AHA) criticized a pooled analysis of prospective studies that found that low sodium intake was associated with an increased risk of death and major cardiovascular events in participants with or without hypertension.

Individuals, groups of individuals, organizations and institutions can submit information through Aug. 26 for the Hearst Health Prize, a partnership between Hearst Health and the Jefferson College of Population Health of Thomas Jefferson University.

Tsunami. The word kept coming up as we researched this issue. Physicians and nurses, trained in a variety of cardiovascular specialties and serving different patient populations, worry that a tsunami of patients is not far away.